The Indian government has been procuring COVID-19 vaccines both from local and foreign firms. Here are some key points related to the procurement process:

• The Indian government has been following a policy of equitable distribution of vaccines among all states and union territories.
• The Health Minister has announced that the government will continue to follow the principle of 'speed, equity, and access' in its procurement process.
• The government has so far procured vaccines from two Indian firms (Serum Institute of India and Bharat Biotech) and one foreign firm (Russia's Gamaleya Research Institute of Epidemiology and Microbiology).
• Indian vaccine manufacturers have also been authorised to supply vaccines to other countries, as India aims to contribute to the global fight against COVID-19.
• The Indian government has also set up a task force to monitor the procurement and distribution of vaccines across the country.

Overall, the Indian government has been proactively managing the procurement process while keeping the welfare of its citizens in mind.